The University of Kentucky Center for Clinical and Translational Science is receiving almost $20 million from the National Institutes of Health. The grant announced Wednesday is expected to further lab-to-bedside patient care.
Dr. Philip Kern says this second multi-year NIH grant will continue efforts to move from studies with mice to trials with human subjects. The director of the UK Center for Clinical and Translational Science says it may involve selective pilot seed money for researchers.
Kern says the work is not disease-specific. He says there are existing centers that concentrate on cancer, Alzheimer’s, and diabetes, “What we do is we provide research infrastructure to all of them so they can all do their work better.”
College of Medicine Dean Robert DiPaola says the funding can help reduce health care disparities in cancer, heart disease, stroke, diabetes, dementia, and substance addiction. He says this work can also help develop cutting edge therapies.